Article
Identification of disease phenotypes in acetylcholine receptor-antibody myasthenia gravis using proteomics-based consensus clustering.
EBioMedicine - 1 Jul 2024
Nelke Christopher, Schroeter Christina B, Barman Sumanta, Stascheit Frauke, Masanneck Lars, Theissen Lukas, Huntemann Niklas, Walli Sara, Cengiz Derya, Dobelmann Vera, Vogelsang Anna, Pawlitzki Marc, Räuber Saskia, Konen Felix F, Skripuletz Thomas, Hartung Hans-Peter, König Simone, Roos Andreas, Meisel Andreas, Meuth Sven G, Ruck Tobias
Abstract excerpt
BACKGROUND: The clinical heterogeneity of myasthenia gravis (MG), an autoimmune disease defined by antibodies (Ab) directed against the postsynaptic membrane, constitutes a challenge for patient stratification and treatment decision making. Novel strategies are needed to classify patients based on their biological phenotypes aiming to improve patient selection and treatment outcomes. METHODS: For this purpose, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
